Skip to main content

Post-IPO Equity Biotechnology Companies

Explore 483 biotechnology startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
483
Total Funding
$1.1B
Avg Funding
$45.1M
Cities
24

Export 483 Post-IPO Equity Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Bothell, United States
$13.2M
raised

YD Bio is a biotechnology business that is developing advancements in ophthalmology and DNA methylation-based cancer detection technology.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Emeryville, United States
$30.0M
raised

OmniAb® provides access to diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Melville, United States
$400.0M
raised

Sharps Technology makes single-use syringes that help prevent accidental needle sticks and make injections safer

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New Haven, United States

Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$120.0M
raised

Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Pointe-claire, Canada
$1.7M
raised

Devonian is a late stage botanical pharmaceutical corporation

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Beverly, United States
$12.0M
raised

BioVie specializes in the development of innovative solutions for the treatment of neurodegenerative and liver diseases.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Wexford, United States
$4.0M
raised

Coeptis Therapeutics is a biopharmaceutical company that focuses on the development and acquisition of cell therapy platforms for patients.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$5.0M
raised

Prime Medicine is a biotechnology company that utilizes Prime Editing to modify genetic sequences to treat a wide range of diseases.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Sydney, Australia
$132.4M
raised

Clarity Pharmaceuticals is a personalized medicine company focused on the treatment of serious disease.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
South San Francisco, United States
$100.0M
raised

Lyell Immunopharma is an operator of a biotechnology company that develops cellular therapies to cure cancer.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Bethesda, United States
$7.0M
raised

Gain Therapeutics is a biotech company developing pharmacological chaperones drugs designed to treat rare metabolic disorders.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Washington, United States
$5.0M
raised

60 Degrees Pharmaceuticals develops and commercializes new medicines to treat and prevent infectious diseases.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Lund, Sweden
$1.8M
raised

SynAct Pharma develops drugs for acute deterioration in inflammatory diseases.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Santa Ana, United States
$2.0M
raised

NKGen Biotech is restoring immune function through the development of unique natural killer (NK) cell therapies for the treatment of cancer.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Boston, United States
$175.0M
raised

Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Guilford, United States
$50.0M
raised

Quantum SI offers Next Generation Protein Sequencing that makes diagnostics digital.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Woburn, United States
$8.5M
raised

Biofrontera is a biopharmaceutical company specializing in photodynamic therapy and topical antibiotics.

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

La Jolla, United States
$19.0M
raised

INmune Bio is developing therapies that harness the patient’s immune system to treat cancer.

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Stockholm, Sweden
$3.0M
raised

Modus Therapeutics is a Swedish drug development company focused on normalizing the lives for patients with Sickle Cell Disease.

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Toronto, Canada
$438K
raised

Psyence develops natural psilocybin products for the treatment of psychological trauma and mental health disorders

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Omaha, United States
$11.0M
raised

Klotho Neurosciences develops disease modifying therapies for age-related cognitive and neurodegenerative disorders and cancer.

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Modalis is a biotech company that develops therapeutics using CRISPR based technology.

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Newark, United States
$24.9M
raised

Rafael Holdings is a company focused on the development of novel cancer therapies.

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Minneapolis, United States
$1.5M
raised

FOXO Technologies transforms the global longevity insurance industry with a next-generation underwriting protocol.

Jun 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 276 to 300 of 483 companies

Ready to Connect with Post-IPO Equity Biotechnology Startups?

Get verified founder emails, funding details, and company data for 483 post-ipo equity biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

483 Biotechnology Post-IPO Equity Startups (November 2026) — Page 12 | VCBacked